Search

Bio Roundup: Duchenne Data, Roche Buys Foundation, IPO Wave & More

BIO ROUNDUP: DUCHENNE DATA, ROCHE BUYS FOUNDATION, IPO WAVE & MORE

Biotech financing is a cyclical thing. Two years ago, the IPO window was unlatched but a number of companies ended up withdrawing their...

PLASMA PROCESSOR

Grifols is a global healthcare company whose mission is to improve the health and well-being of people. Our three divisions -Bioscience,...

 
 
 
 
 
 
As Sarepta Preps Data, FDA Lifts Hold on Solid's Duchenne Gene Therapy

AS SAREPTA PREPS DATA, FDA LIFTS HOLD ON SOLID'S DUCHENNE GENE THERAPY

The race to use gene therapy to treat Duchenne muscular dystrophy, a progressive, deadly genetic disease that affects boys, is heating...

DAIICHI SAYS IT'S READY TO CHANGE THE STANDARD OF CARE FOR ACUTE MYELOID LEUKEMIA - BUT IT'S A WORK IN PROGRESS

Close to 4 years ago, Daiichi Sankyo swooped in to buy little San Diego-based Ambit Biosciences for up to $410 million - $315 million...

 
 
 
16 Tech's 60-Acre Innovation Community Coming Soon to Downtown Indy

16 TECH'S 60-ACRE INNOVATION COMMUNITY COMING SOON TO DOWNTOWN INDY

In case you've missed it, the Indianapolis tech community is booming. Indy is one of 20 finalists for Amazon's second American headquarters...

 
 
 

PHLEBOTOMIST

Grifols is a global healthcare company whose mission is to improve the health and well being of people. Our three divisions -Bioscience,...

New Resource for Microbiologists: Collection of 3,000 Bacteria Genomes Released

NEW RESOURCE FOR MICROBIOLOGISTS: COLLECTION OF 3,000 BACTERIA GENOMES RELEASED

Haemophilus influenzae, a sample of which was deposited to the NCTC collection by Alexander Fleming, from his own nose. The genomes...

 
 
 
Governors Take Center Stage at State Bioscience Economic Development Panel

GOVERNORS TAKE CENTER STAGE AT STATE BIOSCIENCE ECONOMIC DEVELOPMENT PANEL

Governors and policymakers across the country understand value of bioscience jobs whether they be health care, agriculture or industrial....

New Machine Learning Approach Could Accelerate Bioengineering

NEW MACHINE LEARNING APPROACH COULD ACCELERATE BIOENGINEERING

A new approach developed by Zak Costello and Hector Garcia Martin brings the the speed and analytic power of machine learning to bioengineering....

 
 
 
 
 
 
Living Large: Exploration of Diverse Bacteria Signals Big Advance for Gene Function Prediction

LIVING LARGE: EXPLORATION OF DIVERSE BACTERIA SIGNALS BIG ADVANCE FOR GENE FUNCTION PREDICTION

By Massie Santos Ballon In the air, beneath the ocean's surface, and on land, microbes are the minute but mighty forces regulating...

Venture Investors To Raise As Much As $100M To Fund Health Startups

VENTURE INVESTORS TO RAISE AS MUCH AS $100M TO FUND HEALTH STARTUPS

Venture Investors plans to raise up to $100 million for a new, healthcare-focused venture capital fund, the Madison, WI-based firm...

 
 
 
Eli Lilly Bolsters Cancer Drug Pipeline with $110M Deal for AurKa

ELI LILLY BOLSTERS CANCER DRUG PIPELINE WITH $110M DEAL FOR AURKA

Eli Lilly is pulling out its checkbook again to acquire another cancer drug developer, this time inking a deal for early-stage company...

PRECISION BIOSCIENCES TO PRESENT IN VIVO GENE THERAPY AND EX VIVO CANCER IMMUNOTHERAPY DATA AT THE AMERICAN SOCIETY OF GENE & CELL THERAPY ANNUAL MEETING

 
 
 
Codfish Study Employs Target Capture and SMRT Sequencing to Explore Evolution

CODFISH STUDY EMPLOYS TARGET CAPTURE AND SMRT SEQUENCING TO EXPLORE EVOLUTION

Many investigators rely on targeted sequencing approaches for deep dives into genomic regions of interest. By designing specific probes...

Evelo IPO Raises $85M for Microbiome Drugs in Inflammation, Cancer

EVELO IPO RAISES $85M FOR MICROBIOME DRUGS IN INFLAMMATION, CANCER

Evelo Biosciences now has $85 million to spend on its pipeline of drugs that target the human microbiome. The Cambridge, MA-based biotech...